ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer.

Agnieszka K Witkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.